DRMA Competitors & Alternatives
Compare Dermata Therapeutics Inc with similar stocks in the same industry
Biotechnology
DRMA
Main Stock$0.86
Tradestie Score
51
Market Cap
$3.50M
Analyst Upside
+364.5%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.80
|
$133.50M | - | 67 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$5.59
|
$114.01M | - | 67 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$23.37
|
$110.20M | - | 71 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$2.99
|
$84.52M | - | 39 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.38
|
$67.94M | - | 63 | Compare |
|
PALI
Palisade Bio, Inc. Common Stock
|
$1.41
|
$12.21M | 2.4 | 48 | Compare |
|
RNAZ
TransCode Therapeutics, Inc. Common Stock
|
$1.78
|
$8.85M | - | 41 | Compare |
|
ENSC
Ensysce Biosciences, Inc. Common Stock
|
$0.52
|
$7.21M | - | 35 | Compare |
|
BBLG
Bone Biologics Corp Common Stock
|
$0.40
|
$5.01M | - | 55 | Compare |
|
REVB
Revelation Biosciences, Inc. Common Stock
|
$3.79
|
$3.42M | 0.1 | 34 | Compare |
More DRMA Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
225 stocks in this industry